Abstract/References
Peak IgG antibody titers against SARS-CoV-2 spike protein following immunization with the Pfizer/BioNTech BNT162b2 vaccine
Yurie Kobashi, Yuzo Shimazu, Takeshi Kawamura, Yoshitaka Nishikawa, Fumiya Omata, Yudai Kaneko, Tatsuhiko Kodama, Masaharu Tsubokura
Author information
- Yurie Kobashi
Department of General Internal Medicine, Hirata Central Hospital, Hirata, Ishikawa District
Department of Radiation Health Management, Fukushima Medical University School of Medicine - Yuzo Shimazu
Department of Radiation Health Management, Fukushima Medical University School of Medicine
Southern Tohoku Research Institute for Neuroscience - Takeshi Kawamura
Proteomics Laboratory, Isotope Science Center, The University of Tokyo
Laboratory for Systems Biology and Medicine, Research Center for Advanced Science and Technology, The University of Tokyo - Yoshitaka Nishikawa
Department of General Internal Medicine, Hirata Central Hospital, Hirata, Ishikawa District - Fumiya Omata
Department of General Internal Medicine, Hirata Central Hospital, Hirata, Ishikawa District - Yudai Kaneko
Laboratory for Systems Biology and Medicine, Research Center for Advanced Science and Technology, The University of Tokyo
Medical & Biological Laboratories Co., Ltd. - Tatsuhiko Kodama
Laboratory for Systems Biology and Medicine, Research Center for Advanced Science and Technology, The University of Tokyo - Masaharu Tsubokura
Department of General Internal Medicine, Hirata Central Hospital, Hirata, Ishikawa District
Department of Radiation Health Management, Fukushima Medical University School of Medicine
Abstract
This study investigated the immune response and outcome of BNT162b2 vaccination among 12 staff at a hospital in Fukushima, Japan. Blood samples were collected from participants before their first vaccination, with subsequent sampling performed during the participants’ work days for six weeks thereafter. Antibody titers peaked 6-13 days after the second vaccination (days 27-34 after the first), followed by a steady decrease. Six males had significantly lower peak antibody titers than six females (p= 0.016 witht-test); the older six (median age 53 years) had lower antibody titers than the younger six (median age 35 years) but without statistical significance (pvalue=0.24 witht-test).
References
- Angel Y, Spitzer A, Henig O, et al. Association between vaccination With BNT162b2 and incidence of symptomatic and asymptomatic SARS-CoV-2 infections among health care workers. JAMA, 325(24):2457-2465, 2021.
- Boyarsky BJ, Werbel WA, Avery RK, et al. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA, 325(21):2204-2206, 2021.
Figures (2)